| 产品详情 |
| Edit |   |
| Antigenic Specificity | CYLD |
| Clone | n/a |
| Host Species | n/a |
| Reactive Species | human, rat |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-CYLD Antibody |
| Immunogen | E Coli-derived human CYLD recombinant protein (Position: D618-K956). Human CYLD shares 97.6% and 97.9% amino acid (aa) sequence identity with mouse and rat CYLD, respectively.Ig Type: Rabbit IgG |
| Other Names | ubiquitin carboxyl-terminal hydrolase CYLD isoform 2; Ubiquitin carboxyl-terminal hydrolase CYLD; ubiquitin carboxyl-terminal hydrolase CYLD; CYLD lysine 63 deubiquitinase; Deubiquitinating enzyme CYLD; Ubiquitin thioesterase CYLD; Ubiquitin-specific-processing protease CYLD, CYLD; CYLD; EAC; MFT; SBS; TEM; BRSS; CDMT; MFT1; CYLD1; CYLDI; USPL2; CYLD1; KIAA0849 |
| Gene, Accession # | CYLD, Gene ID: 1540, NCBI: NP_001035814.1, UniProt: Q9NQC7 |
| Catalog # | MBS177928 |
| Price | |
| Order / More Info | CYLD Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Hayashi M, Jono H, Shinriki S, Nakamura T, Guo J, Sueta A, Tomiguchi M, Fujiwara S, Yamamoto-Ibusuki M, Murakami K, Yamashita S, Yamamoto Y, Li JD, Iwase H, Ando Y. Clinical significance of CYLD downregulation in breast cancer. Breast Cancer Res Treat, 2014 Feb. 2. Vanecek T, Halbhuber Z, Kacerovska D, Martinek P, Sedivcova M, Carr RA, Slouka D, Michal M, Kazakov DV. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma |
| 产品资料 |
|
|